
WHO WE ARE
Carocell Bio’s leadership team has extensive global experience in drug development and is committed to developing new medicines for patients with inflammatory diseases
Carocell Bio executive team

Dr Mike Davies MD, FRCRS, FRSPSG
Chief Executive Officer
- Over 25 years’ global executive leadership experience in drug development in pharma (Pfizer, AstraZeneca, Shire) and biotech
- Expertise in early-stage development and taking medicines from ideation to the market
- Founder of Carocell Bio
John Nicholson
Chairman
- International experience in the pharmaceutical and chemical industries
- Funded and managed Analytical Services companies
- Advisory Board member of the UK North West Business Fund
- Previous Chairman Gentronix


Ann R. Mackey
Chief Financial Officer
- Successful track record of leadership, launching operational initiatives, attracting talented managers, and developing effective teams.
- Experienced with capital markets, corporate structuring, acquisitions, and venture capital.
Carocell Bio Advisory Team
Professor Fadi Issa
Consultant Burns and Plastic Surgeon
Buckinghamshire Healthcare NHS Trust Hospital & Health Care, Aylesbury , Buckinghamshire

Professor Yvonne Perrie
Scientific Advisor
Internationally recognised expert in the field of liposomesand particulate drug delivery research.

Professor Antony Sedgwick PHD
Scientific Advisor
Experienced biotech executive with over 40 years of experience in the sector

Carocell Bio Support team
Graham Combe
Business Development Director

Priya Kalia, BSc, PhD
Director of Communications

Dave Black
Digital Marketing Director

Ruth James, AAC
Financial Advisor

Jane Davies
Clinical Coordinator
